Brief: Dimerix Loss For Half-Year Attributable A$16 Million
26/02/2026 01:24
Feb 26 (Reuters) - Dimerix Ltd DXB.AX: LOSS FOR HALF-YEAR ATTRIBUTABLE A$16 MILLION HY REVENUES FROM ORDINARY ACTIVITIES A$2.3 MILLION Further company coverage: DXB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions